港股异动 | CRO概念股延续跌势美联储不排除加息可能国内创新药仍处调整周期

智通财经04-19

智通财经APP获悉，CRO概念股延续跌势，截至发稿，泰格医药(03347)跌7.94%，报28.4港元；金斯瑞生物科技(01548)跌5.93%，报10.78港元；康龙化成(03759)跌4.83%，报8.47港元；药明康德(02359)跌4.5%，报32.9港元。消息面上，隔夜美联储官员发布鹰派言论。纽约联储主席威廉姆斯表示，如果数据提醒我们需要通过加息来实现目标，那么我们显然会这样做。此外，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2428570092?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-19 10:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2428570092","market":"us","top_or_hot":-1,"title":"港股异动 | CRO概念股延续跌势 美联储不排除加息可能 国内创新药仍处调整周期","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股延续跌势，截至发稿，泰格医药(03347)跌7.94%，报28.4港元；金斯瑞生物科技(01548)跌5.93%，报10.78港元；康龙化成(03759)跌4.83%，报8.47港元；药明康德(02359)跌4.5%，报32.9港元。消息面上，隔夜美联储官员发布鹰派言论。纽约联储主席威廉姆斯表示，如果数据提醒我们需要通过加息来实现目标，那么我们显然会这样做。此外，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1105177.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | CRO概念股延续跌势 美联储不排除加息可能 国内创新药仍处调整周期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | CRO概念股延续跌势 美联储不排除加息可能 国内创新药仍处调整周期\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-19 10:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1105177.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股延续跌势，截至发稿，泰格医药(03347)跌7.94%，报28.4港元；金斯瑞生物科技(01548)跌5.93%，报10.78港元；康龙化成(03759)跌4.83%，报8.47港元；药明康德(02359)跌4.5%，报32.9港元。消息面上，隔夜美联储官员发布鹰派言论。纽约联储主席威廉姆斯表示，如果数据提醒我们需要通过加息来实现目标，那么我们显然会这样做。此外，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1105177.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2242644610.SGD","symbol_name":"Fidelity China Innovation A-ACC-SGD","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1105177.html","article_id":"2428570092","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428570092","pubTimestamp":1713495318,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"消息面上，隔夜美联储官员发布鹰派言论。此外，亚特兰大联储行长博斯蒂克和明尼阿波利斯联储主席卡什卡利也释放出更为强劲的“鹰”声，加剧了市场对加息的担忧。瑞银策略师近日表示，顽固的通胀和经济强劲增长提高了美联储加息而不是降息的可能性，明年利率最高可能升至6.5%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","BK1574":"生物医药B类股","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","BK1583":"高瓴概念","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","03759":"康龙化成","06978":"永泰生物-B","BK4559":"巴菲特持仓","IVV":"标普500指数ETF","BK4588":"碎股","BK4550":"红杉资本持仓","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","01548":"金斯瑞生物科技","YINN":"三倍做多富时中国ETF-Direxion","YANG":"三倍做空富时中国ETF-Direxion","BK1161":"生物科技","BK4585":"ETF&股票定投概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4581":"高盛持仓","BK4504":"桥水持仓","03347":"泰格医药","SSO":"两倍做多标普500ETF","07226":"XL二南方恒科","02359":"药明康德","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1141":"生命科学工具和服务","SH":"标普500反向ETF","SDS":"两倍做空标普500ETF","BK1576":"医药外包概念","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD"},"translate_title":"Hong Kong stocks change CRO concept stocks continue to decline, the Fed does not rule out the possibility of rate hike, domestic innovative drugs are still in the adjustment cycle","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YINN":1,"YANG":1,"SPY":1,"07226":1,"06978":1,"01548":0.9,"03759":0.9,"02359":0.9,"03347":0.9,"SDS":0.6,"OEF":0.6,"OEX":0.6,"SH":0.6,"SPXU":0.6,"SSO":0.6,"UPRO":0.6,".SPX":0.6,"IVV":0.6,"ESmain":0.6},"content_text":"智通财经APP获悉，CRO概念股延续跌势，截至发稿，泰格医药(03347)跌7.94%，报28.4港元；金斯瑞生物科技(01548)跌5.93%，报10.78港元；康龙化成(03759)跌4.83%，报8.47港元；药明康德(02359)跌4.5%，报32.9港元。消息面上，隔夜美联储官员发布鹰派言论。纽约联储主席威廉姆斯表示，如果数据提醒我们需要通过加息来实现目标，那么我们显然会这样做。此外，亚特兰大联储行长博斯蒂克和明尼阿波利斯联储主席卡什卡利也释放出更为强劲的“鹰”声，加剧了市场对加息的担忧。瑞银策略师近日表示，顽固的通胀和经济强劲增长提高了美联储加息而不是降息的可能性，明年利率最高可能升至6.5%。此外，近日有媒体报道，美国生物安全法案所覆盖的企业名单可能会覆盖更多的中国CRO/CDMO企业。太平洋证券指出，国内创新药仍处调整周期，需求不振，未来从投融资到需求、订单以及业绩的好转仍需时间；创新药CXO表现不佳，整体处于行业周期底部，预计2023业绩增速仅为2.76%，未来从需求的恢复到订单的落地、业绩的改善仍需一定时间；仿制药CXO等细分领域表现亮眼，预计业绩以及订单维持30%的高增速。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428570092"}

港股异动 | CRO概念股延续跌势 美联储不排除加息可能 国内创新药仍处调整周期

精彩评论

港股异动 | CRO概念股延续跌势美联储不排除加息可能国内创新药仍处调整周期